[go: up one dir, main page]

GB0801080D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB0801080D0
GB0801080D0 GBGB0801080.3A GB0801080A GB0801080D0 GB 0801080 D0 GB0801080 D0 GB 0801080D0 GB 0801080 A GB0801080 A GB 0801080A GB 0801080 D0 GB0801080 D0 GB 0801080D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0801080.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Priority to GBGB0801080.3A priority Critical patent/GB0801080D0/en
Publication of GB0801080D0 publication Critical patent/GB0801080D0/en
Priority to PCT/GB2009/000145 priority patent/WO2009093009A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/06Peri-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0801080.3A 2008-01-21 2008-01-21 Therapeutic agents Ceased GB0801080D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0801080.3A GB0801080D0 (en) 2008-01-21 2008-01-21 Therapeutic agents
PCT/GB2009/000145 WO2009093009A1 (en) 2008-01-21 2009-01-20 Fused tricyclic thiophene derivatives as mek inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0801080.3A GB0801080D0 (en) 2008-01-21 2008-01-21 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB0801080D0 true GB0801080D0 (en) 2008-02-27

Family

ID=39166109

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0801080.3A Ceased GB0801080D0 (en) 2008-01-21 2008-01-21 Therapeutic agents

Country Status (2)

Country Link
GB (1) GB0801080D0 (en)
WO (1) WO2009093009A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102020651B (en) 2010-11-02 2012-07-18 北京赛林泰医药技术有限公司 6-aryl amino pyridone formamide MEK (methyl ethyl ketone) inhibitor
CN103204822B (en) 2012-01-17 2014-12-03 上海科州药物研发有限公司 Benzoxazole compounds as protein kinase inhibitors, and preparation method and application thereof
GB201201332D0 (en) 2012-01-26 2012-03-14 Imp Innovations Ltd Method
AU2013337702A1 (en) 2012-11-02 2015-05-21 Merck Patent Gmbh Method of reducing adverse effects in a cancer patient undergoing treatment with a MEK inhibitor
WO2015196072A2 (en) 2014-06-19 2015-12-23 Whitehead Institute For Biomedical Research Uses of kinase inhibitors for inducing and maintaining pluripotency
CN105503884B (en) * 2016-02-17 2017-10-13 上海皓元生物医药科技有限公司 A kind of synthetic method for being used to synthesize the key intermediate of BET protein inhibitors
AU2018270292B2 (en) 2017-05-19 2022-02-10 Nflection Therapeutics, Inc. Fused heteroaromatic-aniline compounds for treatment of dermal disorders
WO2018213810A1 (en) 2017-05-19 2018-11-22 Nflection Therapeutics, Inc. Pyrrolopyridine-aniline compounds for treatment of dermal disorders
MA55141A (en) 2018-11-20 2021-09-29 Nflection Therapeutics Inc CYANOARYL-ANILINE COMPOUNDS FOR THE TREATMENT OF SKIN CONDITIONS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2572750A1 (en) * 2003-09-10 2005-03-17 Anil Koul Heterobicyclic compounds as pharmaceutically active agents
GB0616214D0 (en) * 2006-08-15 2006-09-27 Ucb Sa Therapeutic Agents

Also Published As

Publication number Publication date
WO2009093009A1 (en) 2009-07-30

Similar Documents

Publication Publication Date Title
GB0811304D0 (en) Therapeutic agents
GB0811643D0 (en) New therapeutic agents
GB0908957D0 (en) Therapeutic agents
GB0819593D0 (en) Therapeutic agents
HRP20130041T8 (en) Therapeutic agents
GB0821693D0 (en) Therapeutic agents
GB0723747D0 (en) Therapeutic agents
GB0812309D0 (en) Therapeutic agents
GB0805818D0 (en) Therapeutic agents
GB0801080D0 (en) Therapeutic agents
GB0801081D0 (en) Therapeutic agents
GB0724340D0 (en) Novel Therapeutic Agents
EP2454276A4 (en) Therapeutic agents
GB0723748D0 (en) Therapeutic agents
GB0811715D0 (en) Therapeutic agents
GB0910493D0 (en) Therapeutic agents
GB0815177D0 (en) Therapeutic agents
GB0820275D0 (en) Therapeutic agents
GB0801082D0 (en) Therapeutic agents
GB0812563D0 (en) Therapeutic agents
GB0812558D0 (en) Therapeutic agents
GB0815765D0 (en) New therapeutic agents
GB0725030D0 (en) Therapeutic agents
GB0723751D0 (en) Therapeutic agents
GB0723749D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)